Ravin Reid A, Gottlieb Armand, Pasternac Kyle, Cayne Neal, Schneider Darren, Krishnan Prakash, Marin Michael, Faries Peter L
Division of Vascular Surgery, Mount Sinai Hospital, New York, NY.
Division of Vascular Surgery, Mount Sinai Hospital, New York, NY.
J Vasc Surg. 2015 Sep;62(3):624-30. doi: 10.1016/j.jvs.2015.04.390.
Neck radiation therapy (XRT) can induce carotid artery stenosis and may increase the technical difficulty of endarterectomy. It is considered a relative indication for carotid angioplasty and carotid artery stenting (CAS). This study sought to evaluate differences in CAS embolic potential and restenosis performed on XRT and non-XRT patients.
At three institutions, 366 CAS procedures were performed on 321 patients (XRT, n = 43; non-XRT, n = 323). Mean follow-up was 410 days (median, 282 days; range, 7-1920 days). Patients were observed with duplex ultrasound to assess for restenosis. Additional end points included target lesion revascularization (TLR), myocardial and cerebrovascular events, and perioperative complications. Captured particulate from embolic protection filters was analyzed with photomicroscopy and image analysis software for 27 XRT and 214 non-XRT filters.
XRT patients were more likely to be male and had lower rates of hypertension, coronary artery disease, and diabetes mellitus, although the mean age at procedure did not differ. There was no increase in severe internal carotid tortuosity among XRT patients (XRT: 50% vs non-XRT: 34.7%; P = .06). Indication for CAS did not differ between the two groups, including the number of CAS procedures performed for symptomatic carotid stenosis (XRT: 39.7% vs non-XRT: 39.0%; P = NS). Perioperative outcomes, including the composite 30-day stroke, myocardial infarction, and mortality, were not significantly different (XRT: 2.6% vs non-XRT: 3.9%; P = NS.) There were no significant differences in restenosis rate at the 50% (XRT: 9.4% vs non-XRT: 8.6%; P = NS) or 70% (XRT: 3.5% vs non-XRT: 8.6%; P = NS) threshold. Filter particle analysis revealed that filters from XRT patients had more numerous large particles per filter (1.4 vs 0.7; P < .05) and larger mean particle size (464.1 μm vs 320.0 μm; P < .05). TLR did not differ significantly between the groups.
In contrast to earlier studies, this analysis reveals that there are significant differences in XRT and non-XRT patients undergoing CAS in terms of medical comorbidities and embolic material captured in embolic protection filters. The decreased incidence of atherosclerotic risk factors was observed in XRT patients probably because XRT was the primary factor responsible for carotid stenosis. Despite increased embolic particle size, CAS can be performed safely with no increased morbidity, TLR, or restenosis in XRT patients.
颈部放射治疗(XRT)可导致颈动脉狭窄,并可能增加动脉内膜切除术的技术难度。它被认为是颈动脉血管成形术和颈动脉支架置入术(CAS)的相对适应证。本研究旨在评估接受XRT和未接受XRT患者进行CAS时的栓塞风险和再狭窄差异。
在三个机构,对321例患者进行了366例CAS手术(XRT组,n = 43;非XRT组,n = 323)。平均随访时间为410天(中位数,282天;范围,7 - 1920天)。通过双功超声观察患者以评估再狭窄情况。其他终点包括靶病变血管重建(TLR)、心肌和脑血管事件以及围手术期并发症。对27个XRT组和214个非XRT组的栓塞保护滤器捕获的微粒进行光学显微镜和图像分析软件分析。
XRT组患者男性居多,高血压、冠状动脉疾病和糖尿病的发生率较低,尽管手术时的平均年龄无差异。XRT组患者严重颈内动脉迂曲情况未增加(XRT组:50% vs非XRT组:34.7%;P = 0.06)。两组之间CAS的适应证无差异,包括因有症状性颈动脉狭窄而进行的CAS手术数量(XRT组:39.7% vs非XRT组:39.0%;P =无显著性差异)。围手术期结局,包括30天内的复合性卒中、心肌梗死和死亡率,无显著差异(XRT组:2.6% vs非XRT组:3.9%;P =无显著性差异)。在50%(XRT组:9.4% vs非XRT组:8.6%;P =无显著性差异)或70%(XRT组:3.5% vs非XRT组:8.6%;P =无显著性差异)阈值时的再狭窄率无显著差异。滤器微粒分析显示,XRT组患者的滤器每个滤器有更多的大微粒(1.4个vs 0.7个;P < 0.05)且平均微粒尺寸更大(464.1μm vs 320.0μm;P < 0.05)。两组之间TLR无显著差异。
与早期研究不同,本分析显示接受CAS的XRT组和非XRT组患者在合并症和栓塞保护滤器捕获的栓塞物质方面存在显著差异。XRT组患者动脉粥样硬化危险因素的发生率降低,可能是因为XRT是导致颈动脉狭窄的主要因素。尽管栓塞微粒尺寸增加,但在XRT组患者中进行CAS仍可安全进行,且发病率、TLR或再狭窄均未增加。